Back

Intellia Therapeutics Stock Predictions

Get Instant Access To Today's Top Options List!

View this list for FREE now!

Sell

NTLA
Intellia Therapeutics

Last Price:

38.29

Seasonality Move:

10.02%

7 Day Trial

ALL ACCESS PASS

$ 7

20-cent Gold Stock Has Backing of Major Gold Producers

The time to get in is now BEFORE next drill results are released.

Intellia Therapeutics Stock Forecast

Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 76.3% based on the past 6 years of stock performance.
Intellia Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Intellia Therapeutics Stock Undervalued?
The current Intellia Therapeutics [NTLA] share price is $38.30. The Score for NTLA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Intellia Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 76.3% based on the past 6 years of stock performance.

Intellia Therapeutics Stock Rating

Sell

Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics overpriced?

Intellia Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Intellia Therapeutics Stock Price History

Is NTLA stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Healthcare

Type:

stock

Website:

intelliatx.com

52-Week Data

52-Week High:

78.58

52-Week Low:

32.44

Prediction Charts

Market Cap:

3.37B

Price in USD:

38.30

Volume:

764.67K

Beta:

1.93

Technical Analysis

SMA50:

39.70

SMA100:

41.55

SMA200:

49.82

52-Wk Change:

-46.81%

Stock Predictions

Is Intellia Therapeutics stock public?
Yes, Intellia Therapeutics is a publicly traded company.
What is the Intellia Therapeutics stock quote today?
The Intellia Therapeutics stock price is 38.30 USD today.
How to buy Intellia Therapeutics stock online?
You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-7	40.00	40.03	41.54	39.65
Mar-8	39.98	40.25	41.12	39.50
Mar-9	40.07	37.42	40.34	37.03
Mar-10	36.92	35.82	37.03	34.21
Mar-13	35.39	38.31	38.65	35.25
Mar-14	40.20	40.11	41.55	39.37
Mar-15	39.11	40.88	41.07	38.76
Mar-16	40.84	40.55	41.32	39.63
Mar-17	40.47	39.84	40.49	38.92
Mar-20	39.64	38.27	39.78	37.76
Mar-21	38.80	39.79	39.94	38.25
Mar-22	39.68	37.15	39.73	37.05
Mar-23	37.71	37.18	38.85	36.36
Mar-24	36.84	38.30	38.40	36.46

Intellia Therapeutics Earnings

Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intellia Therapeutics Forecast Revenue Growth

Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and a decrease next year of $0.21 per share.

* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.